A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.
"Daily administration of this antagonist by subcutaneous injection to diet-induced obese mice for 1 week caused a significant increase in food intake, body weight, and glucose intolerance, demonstrating endogenous GLP-1 as a relevant hormone in mammalian energy balance in the obese state."
No comments:
Post a Comment